Introduction: There is a growing appreciation for including a complex, vascularised stroma in three-dimensional (3D) tumour models to recapitulate the native tumour microenvironment in situ. Methods: Using a compartmentalised, biomimetic, 3D cancer model, comprising a central cancer mass surrounded by a vascularised stroma, we have tested the invasive capability of colorectal cancer cells. Results: We show histological analysis of dense collagen I/laminin scaffolds, forming necrotic cores with cellular debris. Furthermore, cancer cells within this 3D matrix form spheroids, which is corroborated with high EpCAM expression. We validate the invasive growth of cancer cells into the stroma through quantitative image analysis and upregulation of known invasive gene markers, including metastasis associated in colon cancer 1, matrix metalloproteinase 7 and heparinase. Tumouroids containing highly invasive HCT116 cancer masses form less complex and less branched vascular networks, recapitulating 'leaky' vasculature associated with highly metastatic cancers. Angiogenic factors regulating this were vascular endothelial growth factor A and hepatocyte growth factor active protein. Where vascular networks were formed with less invasive cancer masses (HT29), higher expression of vascular endothelial cadherin active protein resulted in more complex and branched networks. To eliminate the cell ecell interaction between the cancer mass and stroma, we developed a three-compartment model containing an acellular ring to test the chemoattractant pull from the cancer mass. This resulted in migration of endothelial networks through the acellular ring accompanied by
alignment of vascular networks at the cancer/stroma boundary. Discussion: This work interrogates to the gene and protein level how cancer cells influence the development of a complex stroma, which shows to be directly influenced by the invasive capability of the cancer. ª 2019 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Cancer invasion and three-dimensional disease models
Most research studies into cancer cell behaviour and pathology rely heavily on two-dimensional (2D) monolayers of immortalised cancer cell lines. This does not recapitulate the complex cell-to-cell communication of cancer and stromal cells, the influence of extracellular matrix components and the spatial configuration that promotes cancer growth and metastasis of especially colorectal cancer (CRC) [1, 2] . Increasingly, the focus has now been to mimic the cancer microenvironment and macroenvironment to better understand tumour growth. One approach has been to use spheroids of cancer cells grown on low-attachment tissue culture plates. Although this formation enables cancer cells to communicate with one another and starts to form a 'mass' by releasing low levels of inherent collagen [3] , significant aspects of the tumour environment are still missing. It is for this reason that more complex models using biological scaffolds such as Matrigelâ and collagen are used to create an extracellular matrix to achieve biomimicry and study cancer disease pathways by recreating the tumour microenvironment especially. Patient-derived xenograft (PDx) models are a strong tool for preclinical in vivo models of cancer, especially when orthotopically transplanted. However, a major limitation of PDx models is that the tumour microenvironment cannot be recreated owing to important stromal cells such as cancer-associated fibroblasts and endothelial cells not being explanted with the tumour sample [4] . In addition, the adaptive immune component of cancer resistance cannot accurately be modelled [5] . Novel three-dimensional (3D) models of cancer using a collagen matrix are able to include these components to enable the cancer-stromal cell crosstalk, therefore being able to fill this gap in the biomimicry of cancer disease models.
Progression and metastasis of CRC is a disease process that is understood to originate by gastrointestinal epithelial cells within a healthy tissue that undergo the epithelial-to-mesenchymal transition (EMT). EMT enables cells to migrate to different sites, where once reached, they will revert to an epithelial phenotype, undergoing the so-far minimally researched mesenchymal-to-epithelial transition (MET) to form a new stable colonisation of cancer cells [6] . There are a number of hypotheses on what causes this initial EMT in CRC, including prolonged inflammation causing elevated levels of interleukin-6 [7] and eventually the induction of the EMT transcription factor SNAIL [8] . This process is often furthered by the upregulation of Ecadherin, which will maintain the metastases especially in the lungs after the MET [2] . The initial 'budding' of cell clusters or spheroids (!5 cells) [9] may be initiated by the loss of E-cadherin [10] and then driven by an overexpression of matrix metallopeptidase 9 (MMP9) to break down the surrounding matrix and create a path to a new source of oxygen and nutrients [11] . The newly established invasive body will require a number of factors to survive as a now-independent cluster of cells. Some genes, such as metastasis associated in colon cancer 1 (MACC1), are crucial markers for metastatic CRC, thus being a key regulator in the hepatocyte growth factor (HGF)einduced MET [12] , whereas freely circulating matrix metalloproteinase-7/matrilysin (MMP7) is associated with distant metastasis in CRC [13] . Matrix metalloproteinase 2 (MMP2) 'effectively identifies the presence of CRC' and is activated especially by clustering cells [14] . Furthermore, it has recently been shown that even circulating tumour cells recruit and communicate with endothelial cells to form clusters of tumour-derived endothelial cells [15] . It is also vital for a metastasis to promote vasculature, mainly through the disruption and angiogenesis of local endothelial networks. This remodelling often leads to highly disorganised and leaky vasculature forming around the tumour with a reduced surface area-to-volume ratio and high interstitial pressure [16, 17] . While most tumours form a necrotic and hypoxic core, the outer 'leader cells' of the cancer mass will recruit perivascular support cells for the formation and remodelling of vessels, leading to a constant crosstalk between cancer and stromal cells to promote tumour growth [18] .
Throughout this particular piece of work, we tissue engineered a CRC model using high-density type I monomeric collagen [19, 20] , termed as 'tumouroids'. The stiffness of these tumouroids has been confirmed previously with a modulus/MN m À2 of approximately 1.5 AE 0.4 in a single compressed collagen gel [21] . They consisted of a central cancer mass containing either the highly invasive HCT116 or less invasive HT29 [22, 23] cells and were embedded into a stromal compartment to recapitulate the tumour microenvironment in situ [24] . The stromal compartment in our model is easily manipulated as extracellular matrix components and stromal cell types can be added accordingly. The main question and a major component missing from the current literature is how the original cancer manipulates its cellular surroundings and matrix to grow and infiltrate the tumour margin. We hypothesised that cancer cells invade, unlike controlled proliferation in normal cells, disrupting local stromal cell networks and inherent matrices. In addition, we investigated especially the effect on the surrounding vasculature, without which, no cell population would be able to succeed in its path. Finally, we wanted to create a high-throughput model to quantify tumour growth and the signalling pathway involved in early invasion of cancer.
Materials and methods

Histology and haemotoxylin and eosin staining
Historical patient samples on file from 1989 were obtained from a Royal Free Hospital tissue bank. Before processing, the samples were formalin fixed initially using 10% neutrally buffered formalin (Genta Medical, York, UK) and then stored within cassettes to be processed by the histopathology department at the Royal National Orthopaedic Hospital, Stanmore, UK. The samples were then embedded into blocks and sectioned into 5-mM thick sections. Haemotoxylin and eosin (H&E) staining was carried out using the Leica Autostainer XL (Wetzlar, Germany). All sections were imaged using the Zeiss AxioObersver with ApoTome.2 instrument and software (Zeiss, Oberkochen, Germany).
Cell culture
Human colorectal adenocarcinoma cell lines HT29 and HCT116 (both 'European collection of authenticated cell cultures through Sigma-Aldrich, Dorset, UK) were cultured in Dulbecco's Modified Eagle Medium (DMEM) at 1,000 mg/L glucose (Sigma-Aldrich, Dorset, UK). Human adult donor dermal fibroblasts (HDFs) (PromoCell, Heidelberg, Germany) were cultured in 4,500 mg/L DMEM. Human umbilical vein endothelial cells (HUVECs) were cultured in Endothelial Cell Growth Medium (both from PromoCell, Heidelberg, Germany). Finally, CCD 841 Colon Normal (CCD 841 CoN) cells were cultured in Minimum Essential Medium (MEM) supplemented with 1 mM sodium pyruvate (both from Gibcoä through Fisher Scientific, Loughborough, UK). All media were supplemented with 10% foetal calf serum (First Link, Birmingham, UK) in addition to 100 units/mL penicillin and 100 mg/mL streptomycin (Gibcoä through Fisher Scientific, Loughborough, UK). All cell types were cultured at 5% carbon dioxide (CO 2 ) atmospheric pressure and at 37 C and passaged regularly in 2D monolayers. HDFs and HUVECs were used at passage 5 to avoid differentiation of non-immortalised cell lines.
Fabrication of 3D constructs
All 3D constructs were fabricated under sterile conditions, on ice, using monomeric type I rat tail collagen (First Link, Birmingham, UK) using the RAFTä protocol (Lonza, Slough, UK) as previously described [24] . This consists of adding 10X MEM (Sigma-Aldrich, Dorset, UK) to collagen, adding the corresponding amount of the neutralising agent (17% 10 M NaOH [Sigma-Aldrich, Dorset, UK] in 1 M (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buffer [Gibcoä through Thermo Fisher Scientific, Loughborough, UK]) and finally making up the volume with a cell medium containing the desired cell type and number. This results in 80% collagen, 10% 10X MEM, 6% neutralising agent (N.A.) and 4% cells (8:1:0.6:0.4). For the artificial cancer masses (ACMs), 50,000 cells/ACM were added to the neutralised collagen gel mix within the corresponding DMEM volume; and of which, 240 mL was added to a 96-well plate (Corningâ Costarâ through Sigma-Aldrich, Dorset, UK). The gel mix was then left to cross-link at 37 C for 15 min and subsequently plastic compressed for 15 min at room temperature using the 96-well RAFTä absorbers (Lonza, Slough, UK) to produce a high-density 3D collagen construct. ACMs would then be cultured in 200 mL of a cell-type appropriate medium and cultured at 5% CO 2 atmospheric pressure and 37 C. To produce 'tumouroids', the ACMs would be nested into a stromal compartment to recapitulate the tumour microenvironment appropriately. For the stromal compartment, the ACMs would be placed into a 24well plate (Corningâ Costarâ through Sigma-Aldrich, Dorset, UK) containing 1.3 mL of the nonecross-linked collagen mix. Extracellular matrix components could be added to this stromal compartment within the corresponding DMEM volume. In this case, mouse laminin [25] at 50 mg/mL (0.005% in hydrogel and 0.24% in plastic compressed) (Corningâ through Sigma-Aldrich, Dorset, UK) as well as 25,000 HDFs/sample and 100,000 HUVECs/sample were added until an acellular stromal compartment was required. This whole tumouroid would then again be left to cross-link at 37 C for 15 min and subsequently plastic compressed using the 24-well RAFTä absorbers for 15 min at room temperature (Lonza, Slough, UK). These full tumouroids [24] would then be cultured for up to 21 days in 1.0 mL of cellappropriate media (mix 1:1:1 if necessary) at 5% CO 2 atmospheric pressure and 37 C, and every 48 h, a 50% media change would take place on all constructs. The resulting tumouroids have a thickness of 100e120 mm and collagen concentration of 10% (compared with 0.2% in hydrogels) as plastic compression results in a 48-fold increase in collagen concentration from approximately 2.5 mg/mL to 120 mg/mL [24] . For further technical information on how to fabricate the tumouroids, please refer to the detailed schematic in Fig. 1 A and B. to make a tumouroid. Adapted using SMART-Servier Medical ART. Two-dimensional monolayers of cells are used to first make the artificial cancer mass (ACM) in a 96-well plate. The collagen mix achieves a salmon pink colour when neutral pH is reached. This occurs because of the addition of the neutralising agent containing a strong base because collagen is dissolved in 0.6% acetic acid. For the ACM, 240 mL of collagen mix containing the desired cell type is pipetted into a 96-well plate. The collagen mix is then left to cross-link for 15 min at 37 C. This will harden the collagen gel. A 96-well plateesized RAFTä absorber is then placed on the gel for 15 min, which extracts all the water into the absorbers and increases the collagen density of the hydrogel by a factor of up to 48. The ACM is then sandwiched into the middle of the stromal compartment by first pipetting half the gel mix into the 24-well plate (650 mL), letting this set, laying the ACM on this first sandwich half and then pipetting the second half on top (650 mL). The stromal compartment containing the ACM is then left to set and cross-link completely and then undergoes plastic compression again with a 24-wellesized RAFTä absorber. This results in the complete plastic-compressed tumouroid model, which after experiments, can be used for image analysis, lysed for RNA extraction or used for media lysate analysis. (B) Fabrication of CRC 'tumouroids' using type 1 collagen. Collagen mix for ACMs was pipetted into a 96-well plate cross-linked and plastic compressed (a). The ACM was then placed into the stromal compartment before it had set and subsequently set and compressed (b). To measure invasion patterns, the tumouroid was imaged at one focal plane in 4 positions at 10x magnification (c). CRC, colorectal cancer; 3D, three-dimensional.
Immunofluorescence
The constructs were formalin fixed at desired time points using 10% neutrally buffered formalin (Genta Medical, York, UK) for 30 min and then washed and stored in phosphate-buffered saline (PBS) (Gibcoä through Fisher Scientific, Loughborough, UK). Before staining, the constructs were permeabilised and blocked for 1 h at room temperature using 0.2% Triton X-100 and 1% bovine serum albumin (BSA) (both from Sigma-Aldrich, Dorset, UK) dissolved in the same PBS. Primary antibody incubation was then performed overnight at 4 C. The secondary antibody incubation was carried out the next day for 2.5 h at room temperature. Antibodies were diluted in the same Triton X-100 and BSA solution, and suppliers and source were as follows: primary 1:200 anti-CK20 rabbit D9Z1Z (New England Biolabs, Herts, UK), anti-CD31 mouse JC70/A (Abcam, Cambridge, UK), anti-Vimentin mouse V9 (Santa Cruz, Texas, US) and secondary 1:1000 anti-mouse Alexa Fluorâ 488 IgG H&L ab150113 and anti-rabbit DyLightâ 594 ab96885 (both from Abcam, Cambridge, UK). All targets were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI), using NucBlueä (Invitrogenä through Fisher Scientific, Loughborough, UK).
Measurement of cancer cell invasion and endothelial networks
All constructs were imaged using the Zeiss AxioObserver with ApoTome.2 feature instrument and software (Zeiss, Oberkochen, Germany). To measure the outgrowth ('invasion') from the original ACM boarder into the stromal compartment and orientation of endothelial structures towards ACMs, 4 images were taken at a 10x magnification evenly spaced out in alignment with a clock face at 12, 3, 6 and 9 o'clock on the same focal plane (see Fig. 1c ). This was to randomise the observations and find a truer average per sample rather than measure all points of significance. All samples were assessed for the number of invasive bodies (not included in main data but can be found in Supplementary Graph 1) as well as the distance and cross-sectional surface area of invasion. To analyse the complexity of the endothelial networks within the samples, the same image pattern was taken within the stromal compartment of the tumouroids, and endothelial networks were assessed for number, width and length (not included in main data but can be found in Supplementary Graph 2) of branches in addition to the number of junctions and loops within the networks. The images obtained were then analysed in Fiji ImageJ software [26] , and the results were analysed using GraphPad Prism 7 software along with all data obtained throughout the study.
2.6. RNA extraction, cDNA synthesis, qPCR (quantitative polymerase chain reaction) and enzymelinked immunosorbent assay RNA was extracted using the phase separation TRI Reagentâ and chloroform method [27] (both from Sigma-Aldrich, Dorset, UK). The total RNA obtained was quantified and tested for integrity using the Nano-Dropä. The RNA was then transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystemsä through Fisher Scientific, Loughborough, UK) on the T100ä Thermal Cycler (Bio-Rad, Watford, UK). Primer pairs for gene target candidates selected were designed according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines [28] for an annealing temperature (Ta) of 60 C, with sequences shown in Table 1 in the following section, and ordered through Eurofins Genomics (Ebersberg, Germany). Primer pair parameters can be found in Supplementary Information. Gene target amplification was conducted using the iTaqä Universal SYBRâ Green Supermix on the CFX96ä Touch System (both from Bio-Rad, Watford, UK) in 10 mL reactions placing 20 ng of sample cDNA with a primer concentration of 0.2 mM and run for 40 cycles. Relative gene expression was calculated using the DCt and 2 -DDCt method [29] normalising to the reference gene hypoxanthine-guanine phosphoribosyltransferase (HPRT1) expression, with primer sequences used as previously described [30] . Media samples from tumouroids were taken at every 48-h media change, assessed for PLAU, HGF and vascular endothelial cadherin (VE-cadherin) active protein expression using the R&D Systems (Abingdon, UK) Human Magnetic Luminexâ assay or Human VE-cadherin Quantikine enzyme-linked immunosorbent assay kit according to the manufacturer's instructions and subsequently read on the Bio-Rad Bio-Plexâ MAGPIXä Multiplex Reader (Watford, UK) or the Tecan M200 PRO Microplate Reader (Männedorf, Switzerland).
Optical projection tomography
Tumouroids were imaged at the UCL Centre for Advanced Biomedical Imaging. The samples were formalin fixed using 10% neutrally buffered formalin (Genta Medical, York, UK) for 30 min and then washed in PBS (Gibcoä through Fisher Scientific, Loughborough, UK), permeabilised and stained as mentioned previously with primary 1:200 anti-CK20 rabbit D9Z1Z (New England Biolabs, Herts, UK) and secondary 1:1000 anti-rabbit Alexa Fluorâ 568 IgG H&L ab175473 (both from Abcam, Cambridge, UK) and embedded in 1% agarose at 37 C after being cut into quadrants. Dehydration was conducted using 50%, 80% and 100% ethanol for 24 h each, and replenishment was carried out with alcohol every 12 h. Finally, the samples were optically cleared using benzyl alcohol and benzyl benzoate (1:2). The tumouroids were then imaged using the OPT Scanner 3001M (Bioptonics MRC, Edinburgh, UK), reconstructed using NRecon (SkyScan, Kontich, Belgium) and analysed using MATLAB 2017b and Amira 5.4 TM software. Further information can be found in Supplementary Section.
Statistical analyses
All statistical analyses were performed using GraphPad Prism 7 software. Data were tested for normality using the ShapiroeWilk test (n ! 3) or the D'Agostino test (n ! 8), and then, the appropriate test for statistical significance was applied depending on the data set and its parameters. The tests used for each graph are outlined within the figure legends. Significance was accepted at p-values <0.05. All data points are represented as means with standard error means in graphs, and values, stated in text as means with standard deviations. In general, n Z 3 with 3e4 technical replicates, and this is also further described within the figure legends. Fvalues, t-values and degrees of freedom are also noted within the figure legends for each set of statistical tests. Two-tailed tests for significance were used for tests appropriately.
Results
Biomimetic model of cancer with necrotic cores within spheroid formations
Histological H&E analysis confirmed the similarity in the cell phenotype between the colorectal tumouroid model and that observed in patient samples ( Fig. 2 A  and B) . Necrotic cores within cell clusters were observed ( Fig. 2 B,C and D) , a phenomenon identified as 'dirty necrosis' in CRC [31] . The clustering of cells and the consequent spheroid formation was seen in the less invasive HT29 ACMs, as well as in the highly invasive HCT116 [32] ACMs (Fig. 2 F and G) ; however, the colon normal cells remained as single cells when cultured in a 3D collagen matrix (Fig. 2 E) . This result was underlined by the high expression of the epithelial cell adhesion molecule (EpCAM), which is responsible for cell-to-cell connection and overexpressed in tumours that arise from epithelial tissue [33, 34] . When the mRNA expression of EpCAM was compared between the three constructs, HT29 and HCT116 containing tumouroids showed significantly upregulated expression (both pZ<0.0001) compared with the CCD 841 CoN normal colon cells.
Invasive growth is a cancer-specific phenomenon within tumouroids
Clusters of cells grew and migrated from the ACM into the stromal compartment and formed detached, invasive bodies ( Fig. 3 A,B and C). To validate and term the outgrowth of cancer cells as 'invasion' and not migration, the invasive CRC gene markers MACC1 [35] , MMP7 [36] and heparinase (HPSE) [37] were measured within the constructs containing an acellular stromal compartment at day 21 ( Fig. 3 D,E and F). The results identified that MACC1 was upregulated significantly in HT29 (pZ<0.0001) and HCT116 (p Z 0.0073) tumouroids compared with the CCD 841 CoN constructs. When comparing MMP7 expression, this gene was upregulated in the HT29 tumouroids (p Z 0.0007) compared with the CCD 841 CoN. When comparing the expression of HPSE, HCT116 tumouroids had a significantly higher expression (p Z 0.0013) compared with CCD 841 CoN. The less invasive HT29 tumouroids invaded from the original ACM into the stromal compartment in rounded and well-defined cell clusters resembling tumour 'budding' [2] formation with CK20positive leader cells [24] at the invading edge ( Fig. 3 A, B, C and G). However, the highly invasive HCT116 tumouroids demonstrate heterogenous CK20 sheet-like formations when invading into the surrounding stroma ( Fig. 3 H) . These HCT116 sheets are not rounded and show narrower protrusions towards the leading edge while having frilled edges and no defined boundaries. To further quantify cancer invasion, the distance of outgrowth (termed as 'invasion') and cross-sectional surface area were measured over time ( (p Z 0.0009) of the epidermal growth factor receptor(EGFR) compared with tumouroids containing HT29 cells (Fig. 3 I) . EGFR is highly upregulated in CRC and has been used as a target for monoclonal antibody treatment in combination with chemotherapy [38] . This underlines the fact that the rate of invasion in a complex vascularised stroma, within our model, is determined by aggressiveness of the cancer. Another factor that was significantly upregulated in the HCT116 tumouroids (pZ<0.0001) and released into the media was the active protein form of urokinase-type plasminogen activator (PLAU) (Fig. 3 L) . This is correlated with tumour malignancy and is understood to contribute to tissue degradation to aid metastasis [39] .
Vascular complexity is directly affected by cancer invasion
Within the model, two different levels of vascular complexity were observed. The cancer responds to endothelial cells within its proximity, which was seen through the phenomenon of 'vascular mimicry' (Fig. 4  A) in a number of invasive bodies that had budded from the original ACM into the stromal compartment. Vascular mimicry, especially in CRC, plays a major prognostic role [40] and has been used as a predictor for poor disease outcomes [41] . The endothelial structures that developed within the stromal compartment were more complex for the less invasive HT29 tumouroids compared with the highly invasive HCT116 tumouroids ( Fig. 4 B and C) . The complexity of the endothelial networks was assessed ( Fig. 4 D,E and F) by the number of loops, junctions and branches within the networks. In the presence of HT29 cancer cells, all complexity measures were statistically significantly higher (p Z 0.0002, 0.0093 and 0.0034, respectively) than the HCT116 tumouroids. This points towards the phenomenon that more aggressive cancers are more likely to disrupt vasculogenesis and drive angiogenesis, meaning that the cancer cells interact with the networks and the networks respond. This was further investigated by measuring the expression of a number of genes involved in vasculogenesis and angiogenesis. No significant difference was found in genes such as ANG, ANGPT2 or CTNNB1 (see Supplementary Graph 5). The following genes and proteins showed contrasting differences between the two CRC cell lines: vascular endothelial growth factor A (VEGFA) [17] , the number one driver of angiogenesis, HGF, also a potent angiogenic factor [42] , and VE-cadherin, a major player in vascular junctions and complexity of networks [43] . VEGFA mRNA levels ( Fig. 4 G) were significantly higher in the HCT116 tumouroids by day 21 (p Z 0.0229) as was the active HGF protein (Fig. 4 H) released into the media (p Z 0.0057). The active VE-cadherin protein released into the tumouroid media was measured and showed high expression in both groups during early time points, possibly during the initial formation of endothelial networks (Fig. 4 I) . The results confirmed that over time, the HT29 tumouroids consistently released significantly more VE-cadherin (p Z 0.006) than the HCT116 tumouroids. 
Use of the novel compartmentalised acellular ring model to test chemoattractant gradient
During tumouroid growth, it became clear that endothelial cell structures in the surrounding stroma were affected by the presence and type of ACM [44] . From lower magnification images of the ACM and surrounding stroma ( Fig. 5 A) , it can be seen that the endothelial structures are oriented radially surrounding the ACM. This was validated by measuring the angles of endothelial structures to the ACMs (Fig. 5 B and C) , grouping them into 9 groups of increasing angle size, with 0 being perfectly perpendicular to the edge of the ACM. The results showed that by day 21, most endothelial structures had oriented themselves towards the ACM at an angle of 9 or less. This trend was observed within the HT29 tumouroids, where by day 21, the higher proportion of structures fell into the category of 0e9 (39.26% AE 7.393%). When comparing day 7 with day 14 and day 21, the results showed that within the 0e9 group, the fraction of endothelial structures was significantly increased by day 21 (p Z 0.0341). Furthermore, the same trend was seen for the HCT116 tumouroids, within which by day 21, 41.56% AE 4.582% of endothelial structures were within the 0e9 group of the 9 angle groups. Again, when comparing day 7 values to those of day 14 and day 21, there was a statistically significant increase by day 21 (p Z 0.0146) demonstrating that over time, almost 50% endothelial structures align perpendicular to the cancer. This implies that a chemotactic gradient is created by the ACM within the construct, which attracts the surrounding endothelial cells. This point was validated by placing an acellular ring of compressed collagen in between the ACM and vascularised stromal compartment ( Fig. 5D ) to test the effect of a chemoattractant gradient without cell-to-cell interaction. It was observed that cancer cells and vascular networks moved towards each other indicating a chemoattractive gradient between the two compartments ( Fig. 5 E,F and G).
State-of-the-art imaging approach
Optical projection tomography (OPT), a 3D imaging technology, was used to computationally quantify the total number of invasive bodies as well as total surface area and volume to give three binarised values per quarter (more detail in Supplementary Graph 3) for HT29 tumouroids (Fig. 6 A) . The total number of invasive bodies (Fig. 6 B) 
Discussion
In our biomimetic tissue-engineered 3D CRC model, we were able to demonstrate three novel findings. First, we were able to obtain comparative observations to the golden standard of histopathology. Second, we validated the process of invasive growth as opposed to migration within our model and how the aggressiveness of the cancer dictated the rate of this invasion. Third, the interaction between cancer and the stromal vascular network response was quantified and validated through the use of a novel set-up to demonstrate the chemoattractant pull between cancer and its vascularised stroma.
The tumouroid model is relevant in terms of collagen composition. Some of the most relevant literature regarding collagen composition in tissues is not new. Neuman and Logan report the collagen content of varying tissues. This includes human skin at 72%, rat skin at 63% and cow tibia at 24%. The rat duodenum contained 12% collagen (dry weight), which is directly comparable with the collagen used in tumouroids, up to 10% of this is collagen (also dry weight) [45] .
The preinvasive and hence premetastatic clustering of cancer cells has previously been described as a mechanism regulated by adherent junction protein upregulation. This is associated with the filamentous actin cytoskeleton causing a tensional force to bring cells together with limited interstitial space [32] and the overexpression of EpCAM in gastric cancers [34] . Noncancerous colon cells such as CCD 841 CoN have been used in previous models as a control [22] ; however, their epithelial origin has not been thoroughly validated (as stated by American type culture collection (ATCC)). This leads to the possibility that this particular cell line may be a heterogenous cell population, possibly not entirely made of colon epithelial cells and therefore not serving as a good control when comparing with CRC adenocarcinomas. It is therefore more appropriate that we refer to them as 'colon normal cells' as opposed to healthy colon epithelial cells. An important observation, however, was that these 'normal colon cells' did not form 3D cluster aggregates, but remained as single cells both during the growth phase and the migration phase. The trend of single cell outgrowth due to spatial limitation and proliferative drive from the central mass into the stromal compartment was observed in the normal cells while cancer cells exclusively grew out as cell clusters. This was supported by the overexpression of MACC1, MMP7 and HPSE genes in our tumouroids. MACC1 is a marker for advanced CRC [35] , whereas MMP7 is associated with invasive tumour growth and distant metastasis in CRC [13] . HPSE plays an important role in tumour invasion and is associated with poor prognostic outcomes in gastric cancers [37, 46] . Therefore, the outgrowth in our model can be termed as 'invasion' and mimics the invasive growth pattern of CRC in situ. We have also previously shown that using this same model, an increase in mRNA expression for MMP7 was reflected in an increase in the protein expression for the active form of MMP7 [24] .
HCT116 tumouroids showed a more invasive phenotype in our model, as demonstrated by an increase in the distance and surface area of invasion into the stromal compartment compared with other cell lines in our model. Comparative studies in mice, injected with the two cell lines, demonstrated that HCT116 cells would achieve liver metastasis in 100%, whereas HT29 cells achieved less at 88.9% of samples [47] . It should be pointed out here that more invasive does not always mean more metastatic as intact, rounded clusters are required for successful distant metastases [48] . Within the tumouroid model, HT29 invasive bodies exhibited this phenotype of rounded intact clusters, whereas HCT116 grew as thin sheets with frayed edges and thin protrusions. For observational purposes, HT29 cells may therefore be more beneficial to use within the tumouroids as they demonstrate more defined CK20-positive boundaries. While HT29 cells have a p53 mutation, HCT116 'tolerate' the presence of a nonmutated p53 and overwrite its function [23] . The inherently higher invasive properties of HCT116 CRC cells were underlined furthermore by the overexpression of HPSE. This is in line with previous work having emphasised that HPSE plays a particularly important role in invasion, metastasis and poor prognosis of gastric cancers [49, 37] .
While we observed that endothelial networks forming further from the ACM (approximately 160 mm) were of higher complexity than those closer to the ACM, the other measures were related to vasculogenesis (see Supplementary Graph 6). However, this indicates an interesting interplay between cancer and endothelial cells, which has previously been outlined in the phenomenon of vasculogenic mimicry [50] . As demonstrated in our data, highly invasive cancers disrupt vasculature more than less invasive cancers, which is in direct correlation with the cancer thriving and attempting not only to obtain a higher oxygen and nutrient gradient on the outer cell layer consisting of highly invasive leader cells but also to enter the blood stream to metastasise [51] . For this work, we used VEcadherin as a measure of complexity for the endothelial networks, a strictly endothelial adhesion molecule that controls cellular junctions and blood vessel formation [43] . VE-cadherin was consistently expressed at lower levels at the gene (see Supplementary Graph 5) and active protein level for the less invasive CRC. It is for this reason that the model demonstrates how VEcadherin is crucial in vascular complexity. This is a phenomenon that has been investigated in different types of cancer as a dysfunction of the molecule [52] . Interestingly, VE-cadherin has also been directly implicated in the extravasation of tumour cells [53] , which in turn would support its lower expression in highly invasive CRC. This naturally would lead to the idea of targeting cancer-induced antagonists of VE-cadherin. The research on this particular aspect of the cancer cascade is not particularly uniform, with some groups also arguing that they have found VE-cadherin to be elevated in sera of patients with CRC owing to dissociation with b-catenin complexes [54] . A promising approach has been seen in directing monoclonal antibodies against epitopes of VE-cadherin that would disrupt tumour vasculature but not normal blood vessels [55] . Another potential drug target we investigated was HGF, which has been a promising alternative to VEGFA in pancreatic cancer [56] . The fact that HGF was highly expressed in our HCT116 tumouroids validates the level of measurable biomimicry we can achieve while modelling CRC.
It is important to note that in these particular experiments, we are investigating overall gene expression of all cell types within the tumouroid and not necessarily individual cell populations ('smoothie vs. fruit salad' argument by Thomson [57] ). This is a methodological limitation that a lot of groups are working on surpassing through, for example, prior cell sorting. Unfortunately, we are currently not able to extract a single cell type from our tumouroids when we use cocultures and can therefore not distinguish which cell type is expressing which signalling.
Finally, OPT was used for the first time on plasticcompressed collagen constructs to extract 3D morphological data from the tumouroids. Although the data received were limited owing to time constraints, only allowing for an n Z 1, it was successfully demonstrated that such an imaging technique could be used on this type of sample to provide quantitative data. Providing 3D image data and quantification of a 3D model are vital to appropriately analyse morphological features. OPT has largely been used to look at developmental stages of the mouse embryo and specific target organs of interest. It is a promising tool to use for large-volume high-resolution imaging especially in cancer vasculature [58, 59] .
While there have been great advances in 3D CRC models recently, our model is able to demonstrate hallmarks of cancer with a range of invasive and metastatic properties. We were able to use our platform to create a high-throughput and novel analysis tool to measure distance, surface area and volume of invasion. This also enabled us to answer and validate questions about early steps of invasion and the important interplay between cancer and stromal cells, in particular, the tumour vasculature. Future work could include manipulating the model further to answer even more focussed questions such as how the collagen matrix is remodelled during invasion and what markers are expressed by the cells during this process. These could then pose as important potential drug target candidates.
The ultimate personalised healthcare goal would be to use patient-specific cancer, stromal and immune cells to recreate patient tumours in vitro. Our model could be used as a tool to extensively research various drug treatments on tumours with consideration of the tumour microenvironment, which a lot of models still currently lack. Finally, the development of our 3D model enables hypotheses to be investigated in a structured and accurate manner with great biomimicry and the ability to manipulate single variables at a time.
